Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35738
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMonard, Céline-
dc.contributor.authorMarel, Arnaud-
dc.contributor.authorJoannidis, Michael-
dc.contributor.authorOstermann, Marlies-
dc.contributor.authorPeng, Zhiyong-
dc.contributor.authorDoi, Kent-
dc.contributor.authorDe Rosa, Silvia-
dc.contributor.authorBobek, Ilona-
dc.contributor.authorSokolov, Dmitry-
dc.contributor.authorWu, Vin-Cent-
dc.contributor.authorPremuzic, Vedran-
dc.contributor.authorMehta, Ravindra-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorGarcia, Xaime-
dc.contributor.authorPizarro, Camilo-
dc.contributor.authorZarbock, Alexander-
dc.contributor.authorMilet, Igor-
dc.contributor.authorReis, Thiago-
dc.contributor.authorRomain, Marc-
dc.contributor.authorMc Nicholas, Bairbre-
dc.contributor.authorSchneider, Antoine-
dc.contributor.authorRimmelé, Thomas-
dc.date2025-
dc.date.accessioned2025-04-09T07:05:51Z-
dc.date.available2025-04-09T07:05:51Z-
dc.date.issued2025-04-02-
dc.identifier.citationJournal of Critical Care 2025-04-02; 88en_US
dc.identifier.issn1557-8615-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35738-
dc.description.abstractUp to 14 % of critically ill patients receive renal replacement therapy (RRT) during their ICU stay and are treated with intermittent hemodialysis (IHD) or one of the continuous renal replacement therapy (CRRT) techniques. The choice of a modality (IHD or CRRT) and technique (continuuous veno-venous -hemodialysis (CVVHD), -hemofiltration (CVVH), or - hemodiafiltration (CVVHDF)), and the way it is delivered, may have an impact on outcomes but only few studies addressed this question. We aimed to survey the availability, settings, and clinicians' preferences regarding RRT modalities and techniques in critically ill patients. Between July 2021 and March 2022, we conducted an open online worldwide survey targeting ICU clinicians and consisting of 31 questions. Among the 1174 participants from 73 countries, 94 % indicated their ability to initiate RRT at any time. CRRT was more widely available than IHD (97 % vs 85 %). CVVHDF was the most frequently used CRRT technique (59 %), followed by CVVHD (26 %) and CVVH (16 %). Most participants (70 %) reported having access to at least two CRRT techniques in their unit. Preference for IHD or CRRT varied greatly, depending on the clinical situation. Among CRRT techniques, CVVHD was preferred for removal of small-sized molecules, better hemofilter lifespan and reduced nursing workload. The preferential indications for CVVH included septic shock, removal of middle-sized molecules and fluid overload. The technical settings for CVVH and CVVHDF were very heterogeneous. This international survey underscores the large diversity in RRT practices wordlwide, as well as heterogeneity in beliefs and preferences among intensivists. These data highlight the need for robust comparative trials to identify the optimal RRT modality and technique to improve outcomes in specific clinical situations.en_US
dc.language.isoeng-
dc.subjectContinuous renal replacement therapyen_US
dc.subjectIntensive care uniten_US
dc.subjectIntermittent hemodialysisen_US
dc.subjectOrganization of careen_US
dc.subjectPracticesen_US
dc.subjectRenal replacement therapyen_US
dc.subjectSurveyen_US
dc.titleRenal replacement therapy modalities and techniques in intensive care units: An international survey.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Critical Careen_US
dc.identifier.affiliationService d'anesthésie-réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Service de Médecine Intensive Adulte, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; EA 7426, Pathophysiology of Injury-Induced Immunosuppression, Hospices Civils de Lyon-Biomérieux-Université Claude Bernard Lyon 1, Lyon, France.en_US
dc.identifier.affiliationService d'anesthésie-réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.en_US
dc.identifier.affiliationDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.en_US
dc.identifier.affiliationDepartment of Critical Care, King's College London, Guy's & St Thomas' Hospital, London, UK.en_US
dc.identifier.affiliationDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Hubei, China; Clinical Research Center of Hubei Critical Care Medicine,Wuhan 430071, Hubei, China.en_US
dc.identifier.affiliationDepartment of Emergency and Critical Care Medicine, The University of Tokyo, Tokyo, Japan.en_US
dc.identifier.affiliationCentre for Medical Sciences - CISMed, University of Trento, Trento, Italy; Department of Anesthesia and Intensive Care, Santa Chiara Regional Hospital, Trento, Italy.en_US
dc.identifier.affiliationCentral Department of Anesthesiology and Intensive Care Medicine, Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest, Hungary.en_US
dc.identifier.affiliationDepartment of Anesthesiology and Intensive Care Medicine, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russia.en_US
dc.identifier.affiliationDivision of Nephrology, NSARF (National Taiwan University Hospital Study Group of ARF), National Taiwan University Hospital, Taipei, Taiwan.en_US
dc.identifier.affiliationDepartment of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.en_US
dc.identifier.affiliationDepartment of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.en_US
dc.identifier.affiliationIntensive Careen_US
dc.identifier.affiliationData Analytics Research and Evaluation (DARE) Centreen_US
dc.identifier.affiliationInternational Hospital of Colombia, Heart Institue, Bucaramanga, Colombia.en_US
dc.identifier.affiliationDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.en_US
dc.identifier.affiliationDepartment of Intensive Care, Unidade Local de Saúde Gaia-Espinho, Vila Nova de Gaia, Portugal.en_US
dc.identifier.affiliationHospital Sírio-Libanês, São Paulo, Brazil; Fenix Nefrologia, São Paulo, Brazil.en_US
dc.identifier.affiliationDepartment of Medical Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.en_US
dc.identifier.affiliationDepartment of Anaesthesia and Intensive Care Medicine, School of Medicine, University of Galway, Galway, Ireland.en_US
dc.identifier.affiliationService de Médecine Intensive Adulte, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.en_US
dc.identifier.affiliationService d'anesthésie-réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; EA 7426, Pathophysiology of Injury-Induced Immunosuppression, Hospices Civils de Lyon-Biomérieux-Université Claude Bernard Lyon 1, Lyon, France.en_US
dc.identifier.doi10.1016/j.jcrc.2025.155076en_US
dc.type.contentTexten_US
dc.identifier.pubmedid40179459-
dc.description.volume88-
dc.description.startpage155076-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on May 5, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.